Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication
Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication
复制标题
DOI：
10.1093/bja/aeh269
复制
发表时间：
2004-12-01
影响因子：
9.8
通讯作者：
Pargger, H
中科院分区：
文献类型：
--
作者：
Stotz, M;Thümmler, D;Pargger, H
抗精神病药物恶性症候群是一种罕见的并发症时，使用抗精神病药物。我们报告的情况下，严重的帕金森氏病患者谁开发的抗精神病药物恶性综合征后，他的选择性冠状动脉旁路移植术的抗帕金森病药物撤出。丹曲林钠可能是严重病例的治疗选择。
Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.